Dashboard
Manage Tickers

BNTXBioNTech SE

Nasdaq biontech.de


$ 78.45 $ -0.26 (-0.33 %)    

Tuesday, 02-Jul-2024 15:51:42 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 486.20 $ 6.31 (1.31 %)
DIA $ 392.93 $ 2.09 (0.53 %)
SPY $ 548.17 $ 4.43 (0.81 %)
TLT $ 90.60 $ -0.07 (-0.08 %)
GLD $ 215.59 $ 0.32 (0.15 %)
$ 78.83
$ 78.71
$ 78.42 x 200
$ 0.00 x 0
$ 78.09 - $ 79.21
$ 78.68 - $ 125.83
888,072
na
18.74M
$ 0.07
$ 0.02
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

london-high-court-ruling-fuels-pfizer-and-moderna-legal-dispute-over-covid-19-vaccine-patents
London High Court Ruling Fuels Pfizer And ...
07/02/2024 16:59:34

Pfizer and Moderna continue their legal battle over COVID-19 vaccine patents following a mixed ruling by London's High Cour...

abbviegenmabs-epkinly-fda-approval-is-a-positive-step-analyst-says-additional-expansion-opportunities-underway
AbbVie/Genmab's Epkinly FDA Approval Is A ...
06/27/2024 17:22:09

The FDA has approved Epkinly as the first subcutaneously administered bispecific antibody for adults with relapsed or refractor...

Core News & Articles
Pfizer And BioNTech Receive Positive CHMP ...
06/27/2024 14:31:17

The updated COVID-19 vaccine is tailored to the Omicron JN.1 lineage of SARS-CoV-2 and is recommended for individuals 6 months ...

evaluating-biontech-insights-from-12-financial-analysts
Evaluating BioNTech: Insights From 12 Fina...
06/26/2024 12:00:26

hc-wainwright--co-reiterates-buy-on-biontech-maintains-113-price-target
HC Wainwright & Co. Reiterates Buy on BioN...
06/26/2024 11:13:46

HC Wainwright & Co. analyst Robert Burns reiterates BioNTech (NASDAQ:BNTX) with a Buy and maintains $113 price target.

10-health-care-stocks-whale-activity-in-todays-session
10 Health Care Stocks Whale Activity In To...
06/24/2024 17:35:23

biontech-and-duality-biologics-announced-fda-granted-fast-track-designation-for-bnt324db-1311-for-advancedunresectable-or-metastatic-castration-resistant-prostate-cancer-patients-who-have-progressed-on-or-after-standard-systemic-regimens
BioNTech And Duality Biologics Announced F...
06/24/2024 11:02:05

gamestop-and-first-solar-were-among-the-10-biggest-large-cap-losers-last-week-june-16-june-22-are-these-in-your-portfolio
GameStop And First Solar Were Among The 10...
06/23/2024 15:59:20

10 worst-performing large-cap stocks last week: GME, ENPH, ALB, BNTX, ALGN, FLSR, BALL, MBLY, BLD, JBL. Are they in your portfo...

covid-19-pharma-stars-continue-their-quest-to-set-new-standards-in-cancer-treatment
Covid-19 Pharma Stars Continue Their Quest...
06/18/2024 14:19:12

AstraZeneca PLC (NASDAQ: AZN) kicked off the week by receiving approval from the U.S. Food and Drug Administration for its bloc...

why-is-pfizer-partner-biontech-stock-trading-lower-on-monday
Why Is Pfizer Partner BioNTech Stock Tradi...
06/17/2024 17:22:46

BioNTech partner MediLink Therapeutics faces a partial clinical hold from the FDA on the Phase 1 trial of BNT326/YL202 for adva...

biontech-partner-medilink-therapeutics-says-fda-has-placed-partial-clinical-hold-on-phase-1-trial-of-bnt326yl202-for-heavily-pre-treated-advanced-or-metastatic-egfr-mutated-non-small-cell-lung-cancer-or-hrher2-negative-breast-cancer-6k
BioNTech Partner Medilink Therapeutics Say...
06/17/2024 11:27:12

The partial hold affects the enrollment of new patients in the trial in the U.S.  The FDA has shared with MediLink concerns th...

Core News & Articles
FDA On June 13 Updates Advice To Manufactu...
06/14/2024 18:13:02

- Reuters

evaluating-biontech-insights-from-15-financial-analysts
Evaluating BioNTech: Insights From 15 Fina...
06/10/2024 12:00:42

hc-wainwright--co-reiterates-buy-on-biontech-maintains-113-price-target
HC Wainwright & Co. Reiterates Buy on BioN...
06/10/2024 11:08:39

HC Wainwright & Co. analyst Robert Burns reiterates BioNTech (NASDAQ:BNTX) with a Buy and maintains $113 price target.

moderna-seeks-fda-approval-for-updated-covid-19-shot-for-upcoming-season
Moderna Seeks FDA Approval For Updated COV...
06/07/2024 16:05:42

Moderna has submitted an FDA application for its 2024-2025 Spikevax formula, targeting the prevalent SARS-CoV-2 variant JN.1.

Core News & Articles
FDA Advised Manufacturers Of Authorized Co...
06/07/2024 14:47:41

- Reuters

Core News & Articles
Novavax Says FDA Panel Backs Update For Mo...
06/05/2024 20:36:55

- Bloomberg

Core News & Articles
'First-ever human death of bird flu strain...
06/05/2024 20:22:27

https://globalnews.ca/news/10547712/bird-flu-death-mexico-h5n2/#:~:text=It%20started%20on%20April%2017,to%20complications%20of%...

Core News & Articles
FDA Advisers Support Inclusion Of JN1 COVI...
06/05/2024 19:23:35

- Bloomberg

Core News & Articles
FDA Advisers Vote In Favor Of Recommending...
06/05/2024 18:51:23

- Reuters

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

07/02/2024 Intel Corporation (INTC)
07/05/2024 AXT, Inc. (AXTI)
07/05/2024 Altimmune, Inc. (ALT)
07/09/2024 Li Auto Inc. (LI)
07/12/2024 Inari Medical, Inc. (NARI)
07/12/2024 Sprout Social, Inc. (SPT)
07/15/2024 UnitedHealth Group Inc. (UNH)
07/16/2024 Teladoc Health, Inc. (TDOC)
07/16/2024 Vestis Corporation (VSTS)
07/22/2024 Cambium Networks Corporation (CMBM)

NEW CASE INVESTIGATION

Ooma Inc (OOMA) AnaptysBio Inc (ANAB)